Debt-to-equity of NextCure, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NextCure, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • NextCure, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 41%, a 109% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NextCure, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 41% +21% +109% 31 Dec 2025
Q3 2025 34% +17% +104% 30 Sep 2025
Q2 2025 25% +11% +79% 30 Jun 2025
Q1 2025 21% +8.6% +71% 31 Mar 2025
Q4 2024 19% +9% +87% 31 Dec 2024
Q3 2024 16% +6.5% +65% 30 Sep 2024
Q2 2024 14% +5.8% +70% 30 Jun 2024
Q1 2024 12% +5.5% +82% 31 Mar 2024
Q4 2023 10% +4.9% +89% 31 Dec 2023
Q3 2023 10% +5.8% +141% 30 Sep 2023
Q2 2023 8.3% +4.4% +110% 30 Jun 2023
Q1 2023 6.7% +2.6% +63% 31 Mar 2023
Q4 2022 5.5% +1.4% +34% 31 Dec 2022
Q3 2022 4.2% -0.09% -2.2% 30 Sep 2022
Q2 2022 4% +0.03% +0.7% 30 Jun 2022
Q1 2022 4.1% +0.34% +9% 31 Mar 2022
Q4 2021 4.1% +0.53% +15% 31 Dec 2021
Q3 2021 4.2% -0.95% -18% 30 Sep 2021
Q2 2021 4% -4.1% -51% 30 Jun 2021
Q1 2021 3.8% -7.8% -67% 31 Mar 2021
Q4 2020 3.6% -19% -84% 31 Dec 2020
Q3 2020 5.2% -50% -91% 30 Sep 2020
Q2 2020 8.1% 30 Jun 2020
Q1 2020 12% 31 Mar 2020
Q4 2019 23% 31 Dec 2019
Q3 2019 55% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.